PT1194140E - Composicao farmaceutica contendo fenofibrato e processo de preparacao - Google Patents

Composicao farmaceutica contendo fenofibrato e processo de preparacao

Info

Publication number: PT1194140E
Authority: PT; Portugal
Prior art keywords: pharmaceutical composition; phenofibrate; surfactant; preparation process; cellulose derivative
Prior art date: 1999-07-09

Application number

PT00949677T

Other languages

English (en)

Inventor

Pascal Suplie

Bruno Criere

Philippe Chenevier

Original Assignee

Ethypharm Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-09

Filing date

2000-07-07

Publication date

2005-07-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9547923&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1194140(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-07-07 Application filed by Ethypharm Sa filed Critical Ethypharm Sa

2005-07-29 Publication of PT1194140E publication Critical patent/PT1194140E/pt

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
238000002360 preparation method Methods 0.000 title 1
229920002678 cellulose Polymers 0.000 abstract 3
239000001913 cellulose Substances 0.000 abstract 3
YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 abstract 3
229960002297 fenofibrate Drugs 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 3
239000004094 surface-active agent Substances 0.000 abstract 3
238000004519 manufacturing process Methods 0.000 abstract 2
239000007900 aqueous suspension Substances 0.000 abstract 1
239000011230 binding agent Substances 0.000 abstract 1
238000001035 drying Methods 0.000 abstract 1
239000008187 granular material Substances 0.000 abstract 1
230000007935 neutral effect Effects 0.000 abstract 1
238000012216 screening Methods 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1
238000005507 spraying Methods 0.000 abstract 1
238000009736 wetting Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Diabetes (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PT00949677T 1999-07-09 2000-07-07 Composicao farmaceutica contendo fenofibrato e processo de preparacao PT1194140E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9908923A FR2795961B1 (fr)	1999-07-09	1999-07-09	Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation

Publications (1)

Publication Number	Publication Date
PT1194140E true PT1194140E (pt)	2005-07-29

Family

ID=9547923

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
PT04027226T PT1523983E (pt)	1999-07-09	2000-07-07	Suspensão aquosa contendo fenofibrato
PT05006751T PT1574214E (pt)	1999-07-09	2000-07-07	Composição farmacêutica que contém fenofibrato e processo para a sua preparação
PT00949677T PT1194140E (pt)	1999-07-09	2000-07-07	Composicao farmaceutica contendo fenofibrato e processo de preparacao

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
PT04027226T PT1523983E (pt)	1999-07-09	2000-07-07	Suspensão aquosa contendo fenofibrato
PT05006751T PT1574214E (pt)	1999-07-09	2000-07-07	Composição farmacêutica que contém fenofibrato e processo para a sua preparação

Country Status (37)

Country	Link
US (4)	US7101574B1 (pt)
EP (3)	EP1194140B1 (pt)
JP (2)	JP4841092B2 (pt)
KR (3)	KR20020025188A (pt)
CN (2)	CN1682707B (pt)
AT (3)	ATE291912T1 (pt)
AU (1)	AU782282B2 (pt)
BG (1)	BG65504B1 (pt)
BR (1)	BR0012335A (pt)
CA (1)	CA2377909C (pt)
CY (1)	CY1106206T1 (pt)
CZ (1)	CZ300094B6 (pt)
DE (3)	DE60039313D1 (pt)
DK (3)	DK1194140T3 (pt)
EA (1)	EA004294B1 (pt)
EE (1)	EE04995B1 (pt)
ES (3)	ES2309438T3 (pt)
FR (1)	FR2795961B1 (pt)
GE (1)	GEP20043287B (pt)
HK (3)	HK1044894B (pt)
HR (1)	HRP20020111B1 (pt)
HU (1)	HU229044B1 (pt)
IL (2)	IL147499A0 (pt)
IS (1)	IS2157B (pt)
ME (1)	ME01361B (pt)
MX (1)	MXPA02000324A (pt)
NO (1)	NO333301B1 (pt)
NZ (1)	NZ516416A (pt)
PL (1)	PL212082B1 (pt)
PT (3)	PT1523983E (pt)
RS (1)	RS50035B (pt)
SI (2)	SI1574214T1 (pt)
SK (1)	SK287484B6 (pt)
TR (1)	TR200200008T2 (pt)
UA (1)	UA72925C2 (pt)
WO (1)	WO2001003693A1 (pt)
ZA (1)	ZA200200169B (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7863331B2 (en) *	1999-07-09	2011-01-04	Ethypharm	Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2795961B1 (fr)	1999-07-09	2004-05-28	Ethypharm Lab Prod Ethiques	Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US20080241070A1 (en) *	2000-09-21	2008-10-02	Elan Pharma International Ltd.	Fenofibrate dosage forms
FR2819720B1 (fr) *	2001-01-22	2004-03-12	Fournier Lab Sa	Nouveaux comprimes de fenofibrate
GB0119480D0 (en)	2001-08-09	2001-10-03	Jagotec Ag	Novel compositions
EP2422775A3 (en) *	2002-09-20	2012-04-18	Alpharma, Inc.	Sequestering subunit and related compositions and methods
AU2003263480A1 (en) *	2002-09-24	2004-04-19	Ranbaxy Laboratories Limited	Oral pharmaceutical compositions of fenofibrate having high bioavailability
CN100367947C (zh) *	2002-12-04	2008-02-13	徐州恩华赛德药业有限责任公司	具有抗高血脂症的含非诺贝特的药物组合物
US20080051411A1 (en) *	2002-12-17	2008-02-28	Cink Russell D	Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
EP1832285A1 (en) *	2002-12-17	2007-09-12	Abbott GmbH & Co. KG	Formulation comprising fenofibric acid or a physiologically acceptable salt thereof
RU2356549C2 (ru) *	2002-12-17	2009-05-27	Эббетт ГмбХ унд Ко.КГ	Композиция, включающая фенофибриновую кислоту, ее физиологически приемлемую соль или производное
CA2531097C (en) *	2003-07-02	2012-10-09	Abbott Laboratories	Process for preparing formulations of lipid-regulating drugs
US7264813B2 (en) *	2003-09-24	2007-09-04	Nikken Sohonsha Corporation	Therapeutic uses of Dunaliella powder
US8062664B2 (en)	2003-11-12	2011-11-22	Abbott Laboratories	Process for preparing formulations of lipid-regulating drugs
US8026281B2 (en) *	2004-10-14	2011-09-27	Lupin Atlantis Holdings, S.A.	Treating metabolic syndrome with fenofibrate
EP2281556A1 (en) *	2005-02-25	2011-02-09	F. Hoffmann-La Roche AG	Tablets with improved drugs substance dispersibility
EP1861084A1 (en) *	2005-03-30	2007-12-05	Teva Pharmaceutical Industries Ltd.	Improved formulations of fenofibrate containing menthol or peg/poloxamer
US20080152714A1 (en) *	2005-04-08	2008-06-26	Yi Gao	Pharmaceutical Formulations
US20090210197A1 (en) *	2006-05-23	2009-08-20	Intelemetrix Ltd	Data accessing system and method
CA2655835C (en)	2006-06-19	2015-07-21	Alpharma, Inc.	Abuse-resistant pharmaceutical compositions of opioid agonists
KR100767349B1 (ko) *	2006-08-01	2007-10-17	삼천당제약주식회사	페노피브레이트를 함유하는 경구용 약제 조성물 및 그의제조방법
EP1923053A1 (en) *	2006-09-27	2008-05-21	Novartis AG	Pharmaceutical compositions comprising nilotinib or its salt
EP2073797A2 (en) *	2006-10-11	2009-07-01	Alpharma, Inc.	Pharmaceutical compositions
JP4993274B2 (ja) *	2006-12-05	2012-08-08	日医工株式会社	フェノフィブラート含有製剤組成物の製造方法
AU2008338442A1 (en) *	2007-12-17	2009-06-25	Alpharma Pharmaceuticals, Llc	Pharmaceutical composition
US8623418B2 (en)	2007-12-17	2014-01-07	Alpharma Pharmaceuticals Llc	Pharmaceutical composition
FR2940118B1 (fr) *	2008-12-24	2013-08-09	Ethypharm Sa	Formulation pharmaceutique de fenofibrate nanonise
WO2010092925A1 (ja) *	2009-02-12	2010-08-19	あすか製薬株式会社	固体分散体とその医薬組成物、並びにそれらの製造方法
CN101502497B (zh) *	2009-03-06	2010-11-10	安徽省药物研究所	非诺贝特药物组合物
US20100291201A1 (en) *	2009-05-14	2010-11-18	Cerovene, Inc.	Coated pharmaceutical capsule dosage form
KR101202994B1 (ko) *	2010-04-12	2012-11-21	한미사이언스 주식회사	페노피브린산 및 알칼리화제를 포함하는 경구용 약학 조성물
US20140255480A1 (en) *	2011-09-07	2014-09-11	Ethypharm	Pharmaceutical formulation of nanonized fenofibrate
KR101334585B1 (ko) *	2012-05-29	2013-12-05	주식회사 브이터치	프로젝터를 통해 표시되는 정보를 이용하여 가상터치를 수행하는 원격 조작 장치 및 방법
US8722083B2 (en)	2012-06-25	2014-05-13	Mylan, Inc.	Fenofibrate formulation
WO2014091318A1 (en)	2012-12-11	2014-06-19	Lupin Atlantis Holdings, S.A.	Reduced dose pharmaceutical compositions of fenofibrate
BR112016011628A2 (pt) *	2013-12-04	2017-08-08	Dow Global Technologies Llc	Processo para preparar uma mistura de um derivado de celulose e um diluente líquido
CN104352466A (zh) *	2014-11-17	2015-02-18	辰欣药业股份有限公司	一种非诺贝特组合物及其制剂
CN107961224B (zh) *	2017-12-06	2021-05-04	齐鲁制药(海南)有限公司	一种阿昔替尼片及其制备方法
KR102407512B1 (ko)	2019-10-30	2022-06-13	주식회사 대웅테라퓨틱스	피브레이트계 화합물을 포함하는 근육 질환 예방 및 치료용 조성물
CN112121022A (zh) *	2020-09-25	2020-12-25	迪沙药业集团有限公司	一种非诺贝特片组合物及其制备方法
KR102489384B1 (ko) *	2020-09-29	2023-01-18	애드파마 주식회사	생체이용율이 개선된 페노피브레이트 입자를 포함하는 약제학적 조성물
CN112121023A (zh) *	2020-09-30	2020-12-25	迪沙药业集团有限公司	一种非诺贝特片组合物

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4058552A (en)	1969-01-31	1977-11-15	Orchimed Sa	Esters of p-carbonylphenoxy-isobutyric acids
CH543472A (fr)	1969-01-31	1973-10-31	Orchimed Sa	Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques
GB1579818A (en)	1977-06-07	1980-11-26	Yamanouchi Pharma Co Ltd	Nifedipine-containing solid preparation composition
DE2966564D1 (en)	1978-11-20	1984-02-23	American Home Prod	Therapeutic compositions with enhanced bioavailability and process for their preparation
US4344934A (en)	1978-11-20	1982-08-17	American Home Products Corporation	Therapeutic compositions with enhanced bioavailability
FR2494112B1 (pt)	1980-11-19	1986-01-10	Laruelle Claude
GB8414220D0 (en)	1984-06-04	1984-07-11	Sterwin Ag	Medicaments in unit dose form
GB8414221D0 (en)	1984-06-04	1984-07-11	Sterwin Ag	Unit dosage form
FR2602423B1 (fr)	1986-08-08	1989-05-05	Ethypharm Sa	Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
US4752470A (en)	1986-11-24	1988-06-21	Mehta Atul M	Controlled release indomethacin
US4895725A (en) *	1987-08-24	1990-01-23	Clinical Technologies Associates, Inc.	Microencapsulation of fish oil
FR2627696B1 (fr)	1988-02-26	1991-09-13	Fournier Innovation Synergie	Nouvelle forme galenique du fenofibrate
ATE105710T1 (de)	1990-07-02	1994-06-15	Boehringer Mannheim Gmbh	Verfahren zur herstellung geformter, verpresster dosiseinheiten mit retardierter freisetzung und entsprechende dosiseinheit.
JP3125221B2 (ja) *	1990-09-01	2001-01-15	大正製薬株式会社	ソファルコン含有固形製剤
JP3037393B2 (ja) *	1990-10-22	2000-04-24	大正薬品工業株式会社	経口投与用固形薬剤の製造方法
US5145684A (en)	1991-01-25	1992-09-08	Sterling Drug Inc.	Surface modified drug nanoparticles
US5223268A (en) *	1991-05-16	1993-06-29	Sterling Drug, Inc.	Low solubility drug-coated bead compositions
EP0519144B1 (en) *	1991-06-21	1997-08-13	Ilsan Ilac Ve Hammaddeleri Sanayi A.S.	New galenic process for omeprazole containing pellets
SE9402422D0 (sv)	1994-07-08	1994-07-08	Astra Ab	New beads for controlled release and a pharmaceutical preparation containing the same
FR2722984B1 (fr)	1994-07-26	1996-10-18	Effik Lab	Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US5545628A (en) *	1995-01-10	1996-08-13	Galephar P.R. Inc.	Pharmaceutical composition containing fenofibrate
US5558879A (en) *	1995-04-28	1996-09-24	Andrx Pharmaceuticals, Inc.	Controlled release formulation for water soluble drugs in which a passageway is formed in situ
DE19608750A1 (de)	1996-03-06	1997-09-11	Durachemie Gmbh & Co Kg	Verfahren zur Herstellung von Fenofibrat-Präparaten
AU731704B2 (en) *	1996-06-28	2001-04-05	Schering Corporation	Oral composition comprising a triazole antifungal compound
FR2758461A1 (fr)	1997-01-17	1998-07-24	Pharma Pass	Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
FR2758459B1 (fr) *	1997-01-17	1999-05-07	Pharma Pass	Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
WO1999032612A1 (en) *	1997-12-20	1999-07-01	Genencor International, Inc.	Fluidized bed matrix granule
JP2000086509A (ja) *	1998-09-14	2000-03-28	Taisho Yakuhin Kogyo Kk	ソファルコン含有製剤の製造方法
FR2783421B1 (fr) *	1998-09-17	2000-11-24	Cll Pharma	Procede de preparation de nouvelles formulations galeniques du fenofibrate, formulations galeniques obtenues par ledit procede et leurs applications
US6368620B2 (en) *	1999-06-11	2002-04-09	Abbott Laboratories	Formulations comprising lipid-regulating agents
FR2795961B1 (fr) *	1999-07-09	2004-05-28	Ethypharm Lab Prod Ethiques	Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) *	1999-07-09	2011-01-04	Ethypharm	Pharmaceutical composition containing fenofibrate and method for the preparation thereof
US6667064B2 (en)	2000-08-30	2003-12-23	Pilot Therapeutics, Inc.	Composition and method for treatment of hypertriglyceridemia
AU2001262945B2 (en) *	2000-09-20	2006-02-02	Skyepharma Canada Inc.	Spray drying process and compositions of fenofibrate
US8026281B2 (en)	2004-10-14	2011-09-27	Lupin Atlantis Holdings, S.A.	Treating metabolic syndrome with fenofibrate

1999
- 1999-07-09 FR FR9908923A patent/FR2795961B1/fr not_active Expired - Lifetime
2000
- 2000-07-07 PT PT04027226T patent/PT1523983E/pt unknown
- 2000-07-07 MX MXPA02000324A patent/MXPA02000324A/es active IP Right Grant
- 2000-07-07 UA UA2002021052A patent/UA72925C2/uk unknown
- 2000-07-07 US US10/030,262 patent/US7101574B1/en not_active Expired - Lifetime
- 2000-07-07 ES ES04027226T patent/ES2309438T3/es not_active Expired - Lifetime
- 2000-07-07 CZ CZ20020002A patent/CZ300094B6/cs not_active IP Right Cessation
- 2000-07-07 SK SK15-2002A patent/SK287484B6/sk not_active IP Right Cessation
- 2000-07-07 DK DK00949677T patent/DK1194140T3/da active
- 2000-07-07 NZ NZ516416A patent/NZ516416A/en not_active IP Right Cessation
- 2000-07-07 AT AT00949677T patent/ATE291912T1/de active
- 2000-07-07 ME MEP-2001-932A patent/ME01361B/me unknown
- 2000-07-07 RS YUP-932/01A patent/RS50035B/sr unknown
- 2000-07-07 JP JP2001508973A patent/JP4841092B2/ja not_active Expired - Lifetime
- 2000-07-07 TR TR2002/00008T patent/TR200200008T2/xx unknown
- 2000-07-07 AT AT05006751T patent/ATE341320T1/de active
- 2000-07-07 SI SI200030894T patent/SI1574214T1/sl unknown
- 2000-07-07 AT AT04027226T patent/ATE399006T1/de active
- 2000-07-07 DE DE60039313T patent/DE60039313D1/de not_active Expired - Lifetime
- 2000-07-07 IL IL14749900A patent/IL147499A0/xx active IP Right Grant
- 2000-07-07 PT PT05006751T patent/PT1574214E/pt unknown
- 2000-07-07 PT PT00949677T patent/PT1194140E/pt unknown
- 2000-07-07 EP EP00949677A patent/EP1194140B1/fr not_active Expired - Lifetime
- 2000-07-07 EP EP05006751A patent/EP1574214B1/fr not_active Expired - Lifetime
- 2000-07-07 SI SI200030633T patent/SI1194140T1/xx unknown
- 2000-07-07 CN CN2005100648532A patent/CN1682707B/zh not_active Expired - Lifetime
- 2000-07-07 DK DK04027226T patent/DK1523983T3/da active
- 2000-07-07 ES ES00949677T patent/ES2235919T3/es not_active Expired - Lifetime
- 2000-07-07 KR KR1020027000329A patent/KR20020025188A/ko not_active Application Discontinuation
- 2000-07-07 DK DK05006751T patent/DK1574214T3/da active
- 2000-07-07 CN CNB008101469A patent/CN1204885C/zh not_active Expired - Lifetime
- 2000-07-07 EE EEP200200011A patent/EE04995B1/xx unknown
- 2000-07-07 EA EA200200147A patent/EA004294B1/ru not_active IP Right Cessation
- 2000-07-07 PL PL352307A patent/PL212082B1/pl unknown
- 2000-07-07 CA CA2377909A patent/CA2377909C/fr not_active Expired - Lifetime
- 2000-07-07 EP EP04027226A patent/EP1523983B1/fr not_active Expired - Lifetime
- 2000-07-07 ES ES05006751T patent/ES2271924T3/es not_active Expired - Lifetime
- 2000-07-07 DE DE60031184T patent/DE60031184T2/de not_active Expired - Lifetime
- 2000-07-07 HU HU0202338A patent/HU229044B1/hu not_active IP Right Cessation
- 2000-07-07 DE DE60019120T patent/DE60019120T2/de not_active Expired - Lifetime
- 2000-07-07 AU AU62960/00A patent/AU782282B2/en not_active Expired
- 2000-07-07 BR BR0012335-8A patent/BR0012335A/pt not_active Application Discontinuation
- 2000-07-07 WO PCT/FR2000/001971 patent/WO2001003693A1/fr not_active Application Discontinuation
- 2000-07-07 GE GEAP20006316A patent/GEP20043287B/en unknown
2002
- 2002-01-02 NO NO20020014A patent/NO333301B1/no not_active IP Right Cessation
- 2002-01-03 IS IS6218A patent/IS2157B/is unknown
- 2002-01-04 BG BG106280A patent/BG65504B1/bg unknown
- 2002-01-07 IL IL147499A patent/IL147499A/en unknown
- 2002-01-09 ZA ZA200200169A patent/ZA200200169B/en unknown
- 2002-02-05 HR HR20020111A patent/HRP20020111B1/xx not_active IP Right Cessation
- 2002-08-30 HK HK02106433.0A patent/HK1044894B/zh not_active IP Right Cessation
2005
- 2005-10-04 HK HK05108777A patent/HK1074588A1/xx not_active IP Right Cessation
2006
- 2006-03-09 HK HK06103039A patent/HK1080391A1/xx not_active IP Right Cessation
- 2006-05-29 KR KR1020060048212A patent/KR20060073549A/ko not_active Application Discontinuation
- 2006-08-25 US US11/509,806 patent/US8658212B2/en not_active Expired - Lifetime
- 2006-10-18 CY CY20061101495T patent/CY1106206T1/el unknown
2007
- 2007-02-02 KR KR1020070010902A patent/KR100766644B1/ko active IP Right Grant
2008
- 2008-06-11 US US12/155,937 patent/US20080248101A1/en not_active Abandoned
2010
- 2010-06-25 US US12/823,900 patent/US8563042B2/en not_active Expired - Fee Related
2011
- 2011-03-15 JP JP2011057117A patent/JP2011148813A/ja active Pending

Also Published As

Publication number	Publication date
US8563042B2 (en)	2013-10-22
KR20020025188A (ko)	2002-04-03
KR100766644B1 (ko)	2007-10-15
EP1194140A1 (fr)	2002-04-10
KR20070026716A (ko)	2007-03-08
EP1574214B1 (fr)	2006-10-04
US20110159082A1 (en)	2011-06-30
CY1106206T1 (el)	2011-06-08
HK1080391A1 (en)	2006-04-28
BG65504B1 (bg)	2008-10-31
CN1204885C (zh)	2005-06-08
UA72925C2 (uk)	2005-05-16
EP1523983B1 (fr)	2008-06-25
AU782282B2 (en)	2005-07-14
ME01361B (me)	2008-11-28
PT1523983E (pt)	2008-09-19
RS50035B (sr)	2008-11-28
ZA200200169B (en)	2002-07-31
ATE399006T1 (de)	2008-07-15
FR2795961B1 (fr)	2004-05-28
CZ20022A3 (cs)	2002-05-15
EE200200011A (et)	2003-02-17
FR2795961A1 (fr)	2001-01-12
BR0012335A (pt)	2002-03-19
EP1574214A1 (fr)	2005-09-14
KR20060073549A (ko)	2006-06-28
JP2011148813A (ja)	2011-08-04
US8658212B2 (en)	2014-02-25
HK1074588A1 (en)	2005-11-18
US20070071812A1 (en)	2007-03-29
IS2157B (is)	2006-11-15
DE60031184D1 (de)	2006-11-16
HK1044894B (zh)	2005-06-24
ES2235919T3 (es)	2005-07-16
SK287484B6 (sk)	2010-11-08
CZ300094B6 (cs)	2009-01-28
CA2377909C (fr)	2011-06-28
HRP20020111B1 (en)	2005-12-31
CA2377909A1 (fr)	2001-01-18
ATE341320T1 (de)	2006-10-15
AU6296000A (en)	2001-01-30
JP2003504331A (ja)	2003-02-04
DE60039313D1 (de)	2008-08-07
HU229044B1 (hu)	2013-07-29
NO333301B1 (no)	2013-04-29
WO2001003693A1 (fr)	2001-01-18
SI1194140T1 (en)	2005-06-30
DE60019120D1 (de)	2005-05-04
SI1574214T1 (sl)	2006-12-31
ES2271924T3 (es)	2007-04-16
IS6218A (is)	2002-01-03
HRP20020111A2 (en)	2003-04-30
DK1574214T3 (da)	2007-01-22
PT1574214E (pt)	2007-01-31
CN1682707B (zh)	2010-05-05
DE60031184T2 (de)	2007-08-23
TR200200008T2 (tr)	2002-06-21
EP1523983A1 (fr)	2005-04-20
SK152002A3 (en)	2002-07-02
DK1523983T3 (da)	2008-10-13
US7101574B1 (en)	2006-09-05
NO20020014D0 (no)	2002-01-02
HUP0202338A3 (en)	2003-03-28
NZ516416A (en)	2003-10-31
YU93201A (sh)	2004-09-03
EA200200147A1 (ru)	2002-06-27
CN1360499A (zh)	2002-07-24
JP4841092B2 (ja)	2011-12-21
EA004294B1 (ru)	2004-02-26
GEP20043287B (en)	2004-07-26
EE04995B1 (et)	2008-04-15
DE60019120T2 (de)	2006-02-09
HUP0202338A2 (en)	2002-10-28
BG106280A (en)	2002-08-30
IL147499A (en)	2007-03-08
MXPA02000324A (es)	2002-06-21
ATE291912T1 (de)	2005-04-15
EP1194140B1 (fr)	2005-03-30
PL352307A1 (en)	2003-08-11
ES2309438T3 (es)	2008-12-16
CN1682707A (zh)	2005-10-19
PL212082B1 (pl)	2012-08-31
US20080248101A1 (en)	2008-10-09
IL147499A0 (en)	2002-08-14
DK1194140T3 (da)	2005-07-04
HK1044894A1 (en)	2002-11-08
NO20020014L (no)	2002-03-04

Publication	Publication Date	Title
PT1194140E (pt)	2005-07-29	Composicao farmaceutica contendo fenofibrato e processo de preparacao
BR0012250A (pt)	2002-03-26	Processo de fabricação de grânulos revestidos com gosto mascarado, e liberação imediata do princìpio ativo, grânulo revestido, comprimido multiparticulado de dissolução rápida e comprimido de hidrodispersibilidade rápida
IT1313618B1 (it)	2002-09-09	Derivati di acidi 2-ammino-biciclo(3.1.0)-esan-2,6-bicarbossilici eprocedimento per la loro preparazione.
ES2060784T3 (es)	1994-12-01	Granulos que tienen un nucleo y su produccion.
ATE102044T1 (de)	1994-03-15	Stabilisiertes fgf-mittel und dessen herstellung.
BR0009410A (pt)	2002-02-13	Piridina-2,3-dicarboxamida, composto, uso de uma piridina-2,3-dicarboxamida, composição herbicida, composição para a dessecação e/ou desfolhação de vegetais, e, processo para controlar vegetação não desejável
MX9700564A (es)	1997-05-31	Derivados de benzoilo y sintesis de los mismos.
WO2001095856A3 (en)	2002-06-27	Urea derivative useful as an anti-cancer agent and process for preparing same
EA199700093A1 (ru)	1998-02-26	ЛЕКАРСТВЕННЫЕ ФОРМЫ ДЛЯ ПЕРОРАЛЬНОГО ВВЕДЕНИЯ, СОДЕРЖАЩИЕ β-ЛАКТАМНЫЙ АНТИБИОТИК
HUP9802995A3 (en)	1999-04-28	Substituted sulphonylamino (thio)carbonyl derivatives, intermediates, thereof herbicide compositions containing these compounds as active ingredients, process for the preparation and use of the compounds and compositions
ATE426006T1 (de)	2009-04-15	Pigmentpraparation
BR9601302A (pt)	1998-01-13	Processo para fabricação de um derivado poliglucosamina covalentement ligado derivado poliglucosamina compostos e composição
TR199901044T2 (en)	1999-07-21	Endos�lfan-mikrokaps�l da��l�m�.
SE9902742D0 (sv)	1999-07-20	New pharmaceutical formultion
FR2824069B1 (fr)	2007-03-16	Composition contenant au moins un sulfo-acetate de cellulose et au moins un tensio-actif, son procede de preparation et ses utilisations
WO2002085877A3 (en)	2003-03-06	Processes and intermediates for preparing benzyl substituted epoxides
KR940006583A (ko)	1994-04-25	약제학적 조성물 제조용 보조 혼합물 및 비고체 활성 화합물의 피흡착질
EP1129712A4 (en)	2002-11-05	PREPARATIONS OF QUINOLINONE DERIVATIVES AND THEIR PRODUCTION METHOD
HUT76859A (en)	1997-12-29	4-halo-2-fluoro-5-alkoxybenzoyl derivatives, process for preparing such compounds and intermediates thereof
CA2487540A1 (en)	2005-05-18	Process for the preparation of free-flowing, pulverized atorvastatin adsorbates
BR9709766A (pt)	1999-08-10	Processo de preparação de 2,2'-(1-metil-1,2-etanodilideno)bis(hidrazina carboximidamida)
EP0374125A3 (de)	1990-08-22	Bodenverbesserungsmittel
RU97103465A (ru)	1999-03-20	Прядильный раствор для изготовления модифицированных триацетатцеллюлозных волокон